Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Feb 11;384(6):576-577.
doi: 10.1056/NEJMe2034294. Epub 2020 Dec 2.

A Large, Simple Trial Leading to Complex Questions

David P Harrington  1 , Lindsey R Baden  1 , Joseph W Hogan  1
Affiliations
Editorial

A Large, Simple Trial Leading to Complex Questions

David P Harrington et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    WHO Solidarity Trial Consortium; Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S. WHO Solidarity Trial Consortium, et al. N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2. N Engl J Med. 2021. PMID: 33264556 Free PMC article. Clinical Trial.

Similar articles

See all similar articles

Cited by

  • Remdesivir for the treatment of COVID-19.
    Grundeis F, Ansems K, Dahms K, Thieme V, Metzendorf MI, Skoetz N, Benstoem C, Mikolajewska A, Griesel M, Fichtner F, Stegemann M. Grundeis F, et al. Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2. Cochrane Database Syst Rev. 2023. PMID: 36695483 Free PMC article. Review.
  • XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection.
    Gerber PP, Donde MJ, Matheson NJ, Taylor AI. Gerber PP, et al. Nat Commun. 2022 Nov 16;13(1):6716. doi: 10.1038/s41467-022-34339-w. Nat Commun. 2022. PMID: 36385143 Free PMC article.
  • Evaluating the Clinical Outcomes of Remdesivir Among Patients Admitted With COVID-19 in a Tertiary Care Hospital.
    Butt AG, Ahmed J, Shah SMH, Avendaño Capriles CA, Al-Rihani H, Ahmed B, Salman M, Devi A, Wali S. Butt AG, et al. Cureus. 2021 Nov 11;13(11):e19487. doi: 10.7759/cureus.19487. eCollection 2021 Nov. Cureus. 2021. Retraction in: Cureus. 2022 Mar 17;14(3):r44. doi: 10.7759/cureus.r44. PMID: 34912628 Free PMC article. Retracted.
  • Identification and Development of Therapeutics for COVID-19.
    Rando HM, Wellhausen N, Ghosh S, Lee AJ, Dattoli AA, Hu F, Byrd JB, Rafizadeh DN, Lordan R, Qi Y, Sun Y, Brueffer C, Field JM, Ben Guebila M, Jadavji NM, Skelly AN, Ramsundar B, Wang J, Goel RR, Park Y; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen; Boca SM, Gitter A, Greene CS. Rando HM, et al. mSystems. 2021 Dec 21;6(6):e0023321. doi: 10.1128/mSystems.00233-21. Epub 2021 Nov 2. mSystems. 2021. PMID: 34726496 Free PMC article.
  • SARS-CoV-2-host proteome interactions for antiviral drug discovery.
    Liu X, Huuskonen S, Laitinen T, Redchuk T, Bogacheva M, Salokas K, Pöhner I, Öhman T, Tonduru AK, Hassinen A, Gawriyski L, Keskitalo S, Vartiainen MK, Pietiäinen V, Poso A, Varjosalo M. Liu X, et al. Mol Syst Biol. 2021 Nov;17(11):e10396. doi: 10.15252/msb.202110396. Mol Syst Biol. 2021. PMID: 34709727 Free PMC article.
See all "Cited by" articles

References

    1. WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19 — interim WHO Solidarity trial results. N Engl J Med. DOI: 10.1056/NEJMoa2023184. - DOI - PMC - PubMed
    1. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med 2020;383:1813-1826. - PMC - PubMed
    1. Spinner CD, Gottlieb RL, Criner GJ, et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. JAMA 2020;324:1048-1057. - PMC - PubMed
    1. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020;395:1569-1578. - PMC - PubMed
    1. Rubin D, Chan-Tack K, Farley J, Sherwat A. FDA approval of remdesivir — a step in the right direction. N Engl J Med. DOI: 10.1056/NEJMp2032369. - DOI - PubMed

Substances